PEG-fibrinogen hydrogels for three-dimensional breast cancer cell culture

Journal of Biomedical Materials Research - Part A

Volumn 105, Issue 1, 2017, Pages 236-252

  Pradhan, Shantanu ^a   Hassani, Iman ^a   Seeto, Wen J ^a   Lipke, Elizabeth A ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

biomimetic; cancer tissue engineering; engineered tumor model; mechanical stiffness; tumor microenvironment

Indexed keywords

BIOMIMETICS; CELL CULTURE; CELL PROLIFERATION; CELLS; CYTOLOGY; DISEASES; ELASTIC MODULI; ETHYLENE GLYCOL; POLYETHYLENE GLYCOLS; POLYOLS; SCAFFOLDS (BIOLOGY); TISSUE; TISSUE ENGINEERING; TUMORS;

IMMUNOFLUORESCENCE STAINING; MECHANICAL STIFFNESS; MORPHOLOGICAL CHANGES; POLYETHYLENE GLYCOL DIACRYLATE; SPATIAL HETEROGENEITY; THREEDIMENSIONAL (3-D); TUMOR MICROENVIRONMENT; TUMOR MODELS;

HYDROGELS;

FIBRINOGEN; MACROGOL; MACROGOL DERIVATIVE; POLYETHYLENE GLYCOL 1000;

ARTICLE; BIODEGRADABILITY; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CELL CULTURE; CELL ENCAPSULATION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DEGRADATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYDROGEL; IMMUNOFLUORESCENCE TEST; MCF 7 CELL LINE; MDA MB 231 CELL LINE; SK BR 3 CELL LINE; TISSUE SCAFFOLD; YOUNG MODULUS; BIOLOGICAL MODEL; BREAST TUMOR; CHEMISTRY; DRUG EFFECTS; FEMALE; MCF-7 CELL LINE; METABOLISM; PATHOLOGY; PHARMACOLOGY;

BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; FIBRINOGEN; HUMANS; HYDROGELS; MCF-7 CELLS; MODELS, BIOLOGICAL; POLYETHYLENE GLYCOLS;

EID: 84991449948     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35899     Document Type: Article

References (63)

1. Estrada MF, Rebelo SP, Davies EJ, Pinto MT, Pereira H, Santo VE, Smalley MJ, Barry ST, Gualda EJ, Alves PM, Anderson E, Brito C. Modelling the tumour microenvironment in long-term microencapsulated 3D co-cultures recapitulates phenotypic features of disease progression. Biomaterials 2016;78:50–61.
2. Bray LJ, Binner M, Holzheu A, Friedrichs J, Freudenberg U, Hutmacher DW, Werner C. Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumour angiogenesis. Biomaterials 2015;53:609–620.
3. Chen L, Xiao Z, Meng Y, Zhao Y, Han J, Su G, Chen B, Dai J. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials 2012;33:1437–1444.
4. Szot CS, Buchanan CF, Freeman JW, Rylander MN. 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials 2011;32:7905–7912.
5. de Bono JS, Ashworth A. Translating cancer research into targeted therapeutics. Nature 2010;467:543–549.
6. Cox MC, Reese LM, Bickford LR, Verbridge SS. Toward the broad adoption of 3D tumor models in the cancer drug pipeline. ACS Biomater. Sci Eng 2015;1:877–894.
7. Gu L, Mooney DJ. Biomaterials and emerging anticancer therapeutics: Engineering the microenvironment. Nat Rev Cancer 2015;16:56–66.
8. Carvalho MR, Lima D, Reis RL, Correlo VM, Oliveira JM. Evaluating biomaterial- and microfluidic-based 3D tumor models. Trends Biotechnol 2015;33:667–678.
9. Vantangoli MM, Madnick SJ, Huse SM, Weston P, Boekelheide K. MCF-7 human breast cancer cells form differentiated microtissues in scaffold-free hydrogels. PLoS One 2015;10:e0135426.
10. Krause S, Maffini MV, Soto AM, Sonnenschein C. The microenvironment determines the breast cancer cells' phenotype: Organization of MCF7 cells in 3D cultures. BMC Cancer 2010;10:263.
11. Pradhan S, Chaudhury CS, Lipke EA. Dual-phase, surface tension-based fabrication method for generation of tumor millibeads. Langmuir 2014;30:3817–3825.
12. Gill BJ, Gibbons DL, Roudsari LC, Saik JE, Rizvi ZH, Roybal JD, Kurie JM, West JL. A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model. Cancer Res 2012;72:6013–6023.
13. Yang X, Sarvestani SK, Moeinzadeh S, He X, Jabbari E. Three-dimensional-engineered matrix to study cancer stem cells and tumorsphere formation: Effect of matrix modulus. Tissue Eng. Part A 2013;19:669–684.
14. Fischbach C, Kong HJ, Hsiong SX, Evangelista MB, Yuen W, Mooney DJ. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci USA 2009;106:399–404.
15. Kievit FM, Florczyk SJ, Leung MC, Veiseh O, Park JO, Disis ML, Zhang M. Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment. Biomaterials 2010;31:5903–5910.
16. Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann N Y Acad Sci 2001;936:406–425.
17. Rybarczyk BJ, Simpson-Haidaris PJ. Fibrinogen assembly, secretion, and deposition into extracellular matrix by MCF-7 human breast carcinoma cells. Cancer Res 2000;60:2033–2039.
18. Hall CE, Slayter HS. The fibrinogen molecule: Its size, shape, and mode of polymerization. J Biophys Biochem Cytol 1959;5:11–16.
19. Almany L, Seliktar D. Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 2005;26:2467–2477.
20. Kerscher P, Turnbull IC, Hodge AJ, Kim J, Seliktar D, Easley CJ, Costa KD, Lipke EA. Direct hydrogel encapsulation of pluripotent stem cells enables ontomimetic differentiation and growth of engineered human heart tissues. Biomaterials 2016;83:383–395.
21. Peyton SR, Kim PD, Ghajar CM, Seliktar D, Putnam AJ. The effects of matrix stiffness and RhoA on the phenotypic plasticity of smooth muscle cells in a 3-D biosynthetic hydrogel system. Biomaterials 2008;29:2597–2607.
22. Bearzi C, Gargioli C, Baci D, Fortunato O, Shapira-Schweitzer K, Kossover O, Latronico MV, Seliktar D, Condorelli G, Rizzi R. PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium. Cell Death Dis 2014;5:e1053.
23. Appelman TP, Mizrahi J, Elisseeff JH, Seliktar D. The influence of biological motifs and dynamic mechanical stimulation in hydrogel scaffold systems on the phenotype of chondrocytes. Biomaterials 2011;32:1508–1516.
24. Frisman I, Seliktar D, Bianco-Peled H. Nanostructuring biosynthetic hydrogels for tissue engineering: A cellular and structural analysis. Acta Biomater 2012;8:51–60.
25. Peela N, Sam FS, Christenson W, Truong D, Watson AW, Mouneimne G, Ros R, Nikkhah M. A three dimensional micropatterned tumor model for breast cancer cell migration studies. Biomaterials 2016;81:72–83.
26. Seib FP, Berry JE, Shiozawa Y, Taichman RS, Kaplan DL. Tissue engineering a surrogate niche for metastatic cancer cells. Biomaterials 2015;51:313–319.
27. Zhu W, Wang M, Fu Y, Castro NJ, Fu SW, Zhang LG. Engineering a biomimetic three-dimensional nanostructured bone model for breast cancer bone metastasis study. Acta Biomater 2015;14:164–174.
28. Subia B, Dey T, Sharma S, Kundu SC. Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells. ACS Appl Mater Interfaces 2015;7:2269–2279.
29. Rijal G, Li W. 3D scaffolds in breast cancer research. Biomaterials 2016;81:135–156.
30. Pradhan S, Hassani I, Clary JM, Lipke EA. Polymeric biomaterials for in vitro cancer tissue engineering and drug testing applications. Tissue Eng. Part B Rev. 2016. DOI: 10.1089/ten.teb.2015.0567.
31. Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT, Lorenz K, Lee EH, Barcellos-Hoff MH, Petersen OW. and others. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 2007;1:84–96.
32. Ivascu A, Kubbies M. Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol 2007;31:1403–1413.
33. Feng S, Duan X, Lo PK, Liu S, Liu X, Chen H, Wang Q. Expansion of breast cancer stem cells with fibrous scaffolds. Integr Biol 2013;5:768–777.
34. Hakanson M, Kobel S, Lutolf MP, Textor M, Cukierman E, Charnley M. Controlled breast cancer microarrays for the deconvolution of cellular multilayering and density effects upon drug responses. PLoS One 2012;7:e40141.
35. Dikovsky D, Bianco-Peled H, Seliktar D. The effect of structural alterations of PEG-fibrinogen hydrogel scaffolds on 3-D cellular morphology and cellular migration. Biomaterials 2006;27:1496–1506.
36. Sokic S, Christenson M, Larson J, Papavasiliou G. In Situ Generation of Cell-Laden Porous MMP-Sensitive PEGDA Hydrogels by Gelatin Leaching. Macromol Biosci 2014;14:731–739.
37. Chiu YC, Larson JC, Isom A Jr, Brey EM. Generation of porous poly(ethylene glycol) hydrogels by salt leaching. Tissue Eng. Part C 2010;16:905–912.
38. Karimi M. Diffusion in Polymer Solids and Solutions. In: Jozef Markos, Editor. Mass Transfer in Chemical Engineering Processes. InTech; 2011. pp 1740. ISBN 978-953-307-619-5.
39. Masci VL, Taddei AR, Gambellini G, Giorgi F, Fausto AM. Ultrastructural investigation on fibroblast interaction with collagen scaffold. J Biomed Mater Res A 2016;104:272–282.
40. Faratian D, Munro A, Twelves C, Bartlett JM. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma. Histopathology 2009;54:254–257.
41. Grzanka A, Sujkowska R, Janiak A, Adamska M. Immunogold labelling of PCNA and Ki-67 antigen at the ultrastructural level in laryngeal squamous cell carcinoma and its correlation with lymph node metastasis and histological grade. Acta Histochem 2000;102:139–149.
42. Schmidt MH, Broll R, Bruch HP, Finniss S, Bogler O, Duchrow M. Proliferation marker pKi-67 occurs in different isoforms with various cellular effects. J. Cell Biochem 2004;91:1280–1292.
43. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA. Multicellular tumor spheroids: An underestimated tool is catching up again. J. Biotechnol 2010;148:3–15.
44. Zhou J, Schmid T, Schnitzer S, Brüne B. Tumor hypoxia and cancer progression. Cancer Lett 2006;237:10–21.
45. Oskarsson T. Extracellular matrix components in breast cancer progression and metastasis. Breast 2013;22:S66–S72.
46. Lu P, Weaver VM, Werb Z. The extracellular matrix: A dynamic niche in cancer progression. J. Cell Biol 2012;196:395–406.
47. Costantini V, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SM. Fibrinogen deposition without thrombin generation in primary human breast-cancer tissue. Cancer Res 1991;51:349–353.
48. Kolodziejczyk J, Ponczek MB. The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression. Contemp Oncol (Pozn) 2013;17:113–119.
49. Palumbo JS, Degen JL. Fibrinogen and tumor cell metastasis. Haemostasis 2001;31:11–15.
50. Fenner J, Stacer AC, Winterroth F, Johnson TD, Luker KE, Luker GD. Macroscopic stiffness of breast tumors predicts metastasis. Sci Rep 2014;4:5512.
51. Butcher DT, Alliston T, Weaver VM. A tense situation: Forcing tumour progression. Nat Rev Cancer 2009;9:108–122.
52. Samani A, Zubovits J, Plewes D. Elastic moduli of normal and pathological human breast tissues: An inversion-technique-based investigation of 169 samples. Phys Med Biol 2007;52:1565–1576.
53. Liu J, Tan Y, Zhang H, Zhang Y, Xu P, Chen J, Poh YC, Tang K, Wang N, Huang B. Soft fibrin gels promote selection and growth of tumorigenic cells. Nat Mater 2012;11:734–741.
54. Liu C, Liu Y, Xu XX, Wu H, Xie HG, Chen L, Lu T, Yang L, Guo X, Sun GW, Wang W, Ma XJ, He X. Potential effect of matrix stiffness on the enrichment of tumor initiating cells under three-dimensional culture conditions. Exp Cell Res 2015;330:123–134.
55. Kesselman D, Kossover O, Mironi-Harpaz I, Seliktar D. Time-dependent cellular morphogenesis and matrix stiffening in proteolytically responsive hydrogels. Acta Biomater 2013;9:7630–7639.
56. Stephens TC, Peacock JH. Cell yield and cell survival following chemotherapy of the B16 melanoma. Br J Cancer 1978;38:591–598.
57. Grantab R, Sivananthan S, Tannock IF. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res 2006;66:1033–1039.
58. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009;139:891–906.
59. Cu Y, Saltzman WM. Mathematical modeling of molecular diffusion through mucus. Adv Drug Deliv Rev 2009;61:101–114.
60. Chaudhuri O, Koshy ST, Branco da Cunha C, Shin JW, Verbeke CS, Allison KH, Mooney DJ. Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium. Nat Mater 2014;13:970–978.
61. Peyton SR, Raub CB, Keschrumrus VP, Putnam AJ. The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells. Biomaterials 2006;27:4881–4893.
62. Höckel M, Vaupel P. Tumor Hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266–276.
63. Fang JY, Tan SJ, Yang Z, Tayag C, Han B. Tumor bioengineering using a transglutaminase crosslinked hydrogel. PLoS One 2014;9:e105616.